Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 8 von 173

Details

Autor(en) / Beteiligte
Titel
Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study
Ist Teil von
  • PloS one, 2014-03, Vol.9 (3), p.e91713-e91713
Ort / Verlag
United States: Public Library of Science
Erscheinungsjahr
2014
Quelle
MEDLINE
Beschreibungen/Notizen
  • While the majority of healthcare in the US is provided in community hospitals, the epidemiology and treatment of bloodstream infections in this setting is unknown. We undertook this multicenter, retrospective cohort study to 1) describe the epidemiology of bloodstream infections (BSI) in a network of community hospitals and 2) determine risk factors for inappropriate therapy for bloodstream infections in community hospitals. 1,470 patients were identified as having a BSI in 9 community hospitals in the southeastern US from 2003 through 2006. The majority of BSIs were community-onset, healthcare associated (n = 823, 56%); 432 (29%) patients had community-acquired BSI, and 215 (15%) had hospital-onset, healthcare-associated BSI. BSIs due to multidrug-resistant pathogens occurred in 340 patients (23%). Overall, the three most common pathogens were S. aureus (n = 428, 28%), E. coli (n = 359, 24%), coagulase-negative Staphylococci (n = 148, 10%), though type of infecting organism varied by location of acquisition (e.g., community-acquired). Inappropriate empiric antimicrobial therapy was given to 542 (38%) patients. Proportions of inappropriate therapy varied by hospital (median = 33%, range 21-71%). Multivariate logistic regression identified the following factors independently associated with failure to receive appropriate empiric antimicrobial therapy: hospital where the patient received care (p<0.001), assistance with ≥3 ADLs (p = 0.005), Charlson score (p = 0.05), community-onset, healthcare-associated infection (p = 0.01), and hospital-onset, healthcare-associated infection (p = 0.02). Important interaction was observed between Charlson score and location of acquisition. Our large, multicenter study provides the most complete picture of BSIs in community hospitals in the US to date. The epidemiology of BSIs in community hospitals has changed: community-onset, healthcare-associated BSI is most common, S. aureus is the most common cause, and 1 of 3 patients with a BSI receives inappropriate empiric antimicrobial therapy. Our data suggest that appropriateness of empiric antimicrobial therapy is an important and needed performance metric for physicians and hospital stewardship programs in community hospitals.
Sprache
Englisch
Identifikatoren
ISSN: 1932-6203
eISSN: 1932-6203
DOI: 10.1371/journal.pone.0091713
Titel-ID: cdi_plos_journals_1508464012
Format
Schlagworte
21st century, Aged, Anti-Bacterial Agents - therapeutic use, Antiinfectives and antibacterials, Antimicrobial agents, Bacteremia - drug therapy, Bacteremia - epidemiology, Bacteremia - microbiology, Biology and Life Sciences, Coagulase, Cohort analysis, Communities, Community-Acquired Infections - drug therapy, Community-Acquired Infections - epidemiology, Community-Acquired Infections - microbiology, Comorbidity, Cross Infection - drug therapy, Cross Infection - epidemiology, Cross Infection - microbiology, Data dictionaries, Disease control, Drug Resistance, Bacterial, E coli, Endocarditis, Epidemiology, Escherichia coli - drug effects, Escherichia coli - growth & development, Escherichia coli - isolation & purification, Female, Gram-Negative Bacterial Infections - drug therapy, Gram-Negative Bacterial Infections - epidemiology, Gram-Negative Bacterial Infections - microbiology, Health care, Hospitals, Hospitals, Community, Humans, Infections, Infectious diseases, Male, Medical personnel, Medication Errors, Medicine and Health Sciences, Microbial Sensitivity Tests, Middle Aged, Mortality, Multidrug resistance, Nosocomial infections, Pathogens, Patients, Pediatrics, Physicians, Pseudomonas aeruginosa - drug effects, Pseudomonas aeruginosa - growth & development, Pseudomonas aeruginosa - isolation & purification, Research and Analysis Methods, Retrospective Studies, Risk analysis, Risk factors, Staphylococcal Infections - drug therapy, Staphylococcal Infections - epidemiology, Staphylococcal Infections - microbiology, Staphylococcus aureus, Staphylococcus aureus - drug effects, Staphylococcus aureus - growth & development, Staphylococcus aureus - isolation & purification, Staphylococcus infections, Studies, Therapy, Trends, United States - epidemiology

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX